These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26754924)

  • 61. Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
    Arnaud L; Mertz P; Gavand PE; Martin T; Chasset F; Tebacher-Alt M; Lambert A; Muller C; Sibilia J; Lebrun-Vignes B; Salem JE
    Ann Rheum Dis; 2019 Apr; 78(4):504-508. PubMed ID: 30793701
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in India.
    Kumar V; Kalaiselvan V; Kumar AP; Saurabh A; Thota P; Sidhu S; Medhi B
    Indian J Pharmacol; 2018; 50(4):204-207. PubMed ID: 30505057
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase
    Meincke R; Pokladnikova J; Straznicka J; Meyboom RHB; Niedrig D; Russmann S; Jahodar L
    Pediatr Allergy Immunol; 2017 Nov; 28(7):668-674. PubMed ID: 28846157
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.
    Montastruc J; Marque P; Moulis F; Bourg V; Lambert V; Durrieu G; Montastruc JL; Montastruc F
    Dev Med Child Neurol; 2017 Mar; 59(3):329-334. PubMed ID: 27682175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System.
    Marwitz K; Jones SC; Kortepeter CM; Dal Pan GJ; Muñoz MA
    Drug Saf; 2020 May; 43(5):457-465. PubMed ID: 31981082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overview of HIV treatment failure in Africa using the WHO Pharmacovigilance data.
    Miantezila Basilua J; Mesia Kahunu G; Pochart P; Tona Lutete G
    Trop Med Int Health; 2021 May; 26(5):530-534. PubMed ID: 33529447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
    Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
    Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy.
    Leporini C; De Sarro C; Palleria C; Caccavo I; Piro B; Citraro R; De Sarro G
    Drug Saf; 2022 Nov; 45(11):1381-1402. PubMed ID: 36112324
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase.
    Roselli A; Khouri C; Roustit M; Blaise S; Cracowski JL
    Dermatol Surg; 2019 Dec; 45(12):1517-1528. PubMed ID: 30829775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a multivariate prediction model to identify individual case safety reports which require clinical review.
    Gosselt HR; Bazelmans EA; Lieber T; van Hunsel FPAM; Härmark L
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1300-1307. PubMed ID: 36251280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase).
    Buccellato E; Biagi C; Vaccheri A; Melis M; Montanaro N; Motola D
    Expert Opin Drug Saf; 2013 Sep; 12(5):615-9. PubMed ID: 23701188
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
    Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
    Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Strengthening the Pharmacovigilance System in Mexico: Implementation of VigiFlow and VigiLyze, as ICSR and Signal Detection Management Systems.
    Rayón-Ramírez G; Alvarado-López S; Camacho-Sandoval R; Loera MJ; Svarch AE; Alcocer-Varela J
    Pharmaceut Med; 2023 Nov; 37(6):425-437. PubMed ID: 37804414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.
    Bahk CY; Goshgarian M; Donahue K; Freifeld CC; Menone CM; Pierce CE; Rodriguez H; Brownstein JS; Furberg R; Dasgupta N
    Pharmaceut Med; 2015; 29(6):331-340. PubMed ID: 26635479
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
    Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.
    Anquetil C; Salem JE; Lebrun-Vignes B; Touhami S; Desbois AC; Maalouf G; Domont F; Allenbach Y; Cacoub P; Bodaghi B; Saadoun D
    J Autoimmun; 2020 Jul; 111():102454. PubMed ID: 32303423
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Status of documentation grading and completeness score for Indian individual case safety reports.
    Vivekanandan K; Rishi K; Prasad T; Arunabh T; Singh GN
    Indian J Pharmacol; 2015; 47(3):325-7. PubMed ID: 26069373
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study.
    Phan M; Cheng C; Dang V; Wu E; Muñoz MA
    Ther Innov Regul Sci; 2023 Sep; 57(5):1062-1073. PubMed ID: 37351842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase.
    Vallejo-Yagüe E; Weiler S; Micheroli R; Burden AM
    Drug Saf; 2020 Sep; 43(9):881-891. PubMed ID: 32533433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.